16 Mar 2017 --- Swiss biosynthetic company that develops ingredients and processes for nutrition, healthcare and wellness products, Evolva, has announced that its entering into a Standby Equity Distribution Agreement (SEDA) with a fund managed by Yorkville Advisors Global, LLC (Yorkville).
